Your browser doesn't support javascript.
loading
Successful thrombectomy is beneficial in patients with pre-stroke disability: Results from an international multicenter cohort study.
Ducroux, Célina; Derex, Laurent; Nourredine, Mikaïl; Haesebaert, Julie; Buisson, Marielle; Alesefir, Walid; Boisseau, William; Daneault, Nicole; Deschaintre, Yan; Diestro, Jose Danilo B; Eker, Omer; Eneling, Johanna; Gioia, Laura C; Iancu, Daniella; Jacquin, Grégory; Odier, Céline; Stapf, Christian; Raymond, Jean; Roy, Daniel; Weill, Alain; Lapergue, Bertrand; Poppe, Alexandre Y.
Afiliación
  • Ducroux C; Department of Neurosciences, Faculté de médecine, Université de Montréal, Montréal, QC, Canada; Department of Medicine (Neurology), Centre Hospitalier de l'Université de Montréal, 900 rue St-Denis, Bureau R04-758, Montréal, QC H2X 0A9, Canada.
  • Derex L; Department of Neurology, Stroke Center, Neurological Hospital, Hospices Civils de Lyon, University of Lyon, France; Research on Healthcare Performance (RESHAPE), INSERM U1290, University Claude Bernard Lyon 1, Lyon, France.
  • Nourredine M; Department of Research and Epidemiology, Pôle de Santé Publique, Hospices Civils de Lyon, Lyon, France; Department of pharmaco-toxicology, Hospices Civils de Lyon, Lyon, France.
  • Haesebaert J; Department of Research and Epidemiology, Pôle de Santé Publique, Hospices Civils de Lyon, Lyon, France; Department of pharmaco-toxicology, Hospices Civils de Lyon, Lyon, France.
  • Buisson M; Clinical Investigation Center, INSERM 1407, Louis Pradel Hospital, Hospices Civils de Lyon, Lyon, France.
  • Alesefir W; Department of Neurosciences, Faculté de médecine, Université de Montréal, Montréal, QC, Canada; Department of Medicine (Neurology), Centre Hospitalier de l'Université de Montréal, 900 rue St-Denis, Bureau R04-758, Montréal, QC H2X 0A9, Canada.
  • Boisseau W; Department of Radiology, Centre Hospitalier de l'Université de Montréal, Montréal, QC, Canada.
  • Daneault N; Department of Neurosciences, Faculté de médecine, Université de Montréal, Montréal, QC, Canada; Department of Medicine (Neurology), Centre Hospitalier de l'Université de Montréal, 900 rue St-Denis, Bureau R04-758, Montréal, QC H2X 0A9, Canada; Neurovascular Group, Neurosciences Axis, Centre de Reche
  • Deschaintre Y; Department of Neurosciences, Faculté de médecine, Université de Montréal, Montréal, QC, Canada; Department of Medicine (Neurology), Centre Hospitalier de l'Université de Montréal, 900 rue St-Denis, Bureau R04-758, Montréal, QC H2X 0A9, Canada; Neurovascular Group, Neurosciences Axis, Centre de Reche
  • Diestro JDB; Department of Radiology, Centre Hospitalier de l'Université de Montréal, Montréal, QC, Canada.
  • Eker O; Department of Neuroradiology, Neurological Hospital, Hospices Civils de Lyon, Lyon, France.
  • Eneling J; Department of Radiology, Centre Hospitalier de l'Université de Montréal, Montréal, QC, Canada.
  • Gioia LC; Department of Neurosciences, Faculté de médecine, Université de Montréal, Montréal, QC, Canada; Department of Medicine (Neurology), Centre Hospitalier de l'Université de Montréal, 900 rue St-Denis, Bureau R04-758, Montréal, QC H2X 0A9, Canada; Neurovascular Group, Neurosciences Axis, Centre de Reche
  • Iancu D; Department of Radiology, Centre Hospitalier de l'Université de Montréal, Montréal, QC, Canada.
  • Jacquin G; Department of Neurosciences, Faculté de médecine, Université de Montréal, Montréal, QC, Canada; Department of Medicine (Neurology), Centre Hospitalier de l'Université de Montréal, 900 rue St-Denis, Bureau R04-758, Montréal, QC H2X 0A9, Canada; Neurovascular Group, Neurosciences Axis, Centre de Reche
  • Odier C; Department of Neurosciences, Faculté de médecine, Université de Montréal, Montréal, QC, Canada; Department of Medicine (Neurology), Centre Hospitalier de l'Université de Montréal, 900 rue St-Denis, Bureau R04-758, Montréal, QC H2X 0A9, Canada; Neurovascular Group, Neurosciences Axis, Centre de Reche
  • Stapf C; Department of Neurosciences, Faculté de médecine, Université de Montréal, Montréal, QC, Canada; Department of Medicine (Neurology), Centre Hospitalier de l'Université de Montréal, 900 rue St-Denis, Bureau R04-758, Montréal, QC H2X 0A9, Canada; Neurovascular Group, Neurosciences Axis, Centre de Reche
  • Raymond J; Department of Radiology, Centre Hospitalier de l'Université de Montréal, Montréal, QC, Canada.
  • Roy D; Department of Radiology, Centre Hospitalier de l'Université de Montréal, Montréal, QC, Canada.
  • Weill A; Department of Radiology, Centre Hospitalier de l'Université de Montréal, Montréal, QC, Canada.
  • Lapergue B; Department of Neurology, Foch Hospital, Suresnes, France.
  • Poppe AY; Department of Neurosciences, Faculté de médecine, Université de Montréal, Montréal, QC, Canada; Department of Medicine (Neurology), Centre Hospitalier de l'Université de Montréal, 900 rue St-Denis, Bureau R04-758, Montréal, QC H2X 0A9, Canada; Neurovascular Group, Neurosciences Axis, Centre de Reche
J Neuroradiol ; 50(1): 59-64, 2023 Feb.
Article en En | MEDLINE | ID: mdl-35341899
ABSTRACT

BACKGROUND:

Patients with pre-stroke disability, defined as a modified Rankin Scale (mRS) ≥3, were excluded from most trials of endovascular thrombectomy (EVT) for acute stroke. We sought to evaluate the prognostic factors associated with favorable outcome in stroke patients with known disability undergoing EVT, and the impact of successful reperfusion.

METHODS:

Consecutive acute stroke patients with pre-stroke disability, undergoing EVT, were retrospectively collected between 2016 to 2019 from a Canadian cohort and a multicenter French cohort (Endovascular Treatment in Ischemic Stroke registry-ETIS). Favorable outcome was defined as an mRS equal to pre-stroke mRS. Patients achieving successful reperfusion (defined as a modified Thrombolysis in Cerebral Infarction score of 2b/3) were compared with patients without successful reperfusion to determine if successful EVT was associated with better functional outcomes.

RESULTS:

Among 6220 patients treated with EVT, 280 (4.5%) patients with a pre-stroke mRS ≥3 were included. Sixty-one patients (21.8%) had a favorable outcome and 146 (52.1%) died at 3 months. Patients with successful reperfusion had a higher proportion of favorable 90-day mRS (27.6% versus 19.6%, p = 0.025) and a lower mortality (48.3% versus 69.6%, p = 0.008) than patients without successful reperfusion. After adjusting for baseline prognostic factors, successful reperfusion defined by TICI ≥2b was associated with favorable functional outcome (OR 3.16 CI95% [1.11-11.5]; p 0.048).

CONCLUSION:

In patients with pre-stroke disability, successful reperfusion is associated with a greater proportion of favorable outcome and lower mortality.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Isquemia Encefálica / Accidente Cerebrovascular / Procedimientos Endovasculares Tipo de estudio: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans País/Región como asunto: America do norte Idioma: En Año: 2023 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Isquemia Encefálica / Accidente Cerebrovascular / Procedimientos Endovasculares Tipo de estudio: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans País/Región como asunto: America do norte Idioma: En Año: 2023 Tipo del documento: Article